{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T18:06:07Z","timestamp":1776189967282,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":32,"publisher":"Springer US","isbn-type":[{"value":"9781071621677","type":"print"},{"value":"9781071621684","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-2168-4_9","type":"book-chapter","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T17:05:21Z","timestamp":1643907921000},"page":"155-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Generation of Replication Deficient Human Adenovirus 5 (Ad5) Vectored FMD Vaccines"],"prefix":"10.1007","author":[{"given":"Gisselle N.","family":"Medina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"de los Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fayna","family":"D\u00edaz-San Segundo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"issue":"1","key":"9_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0168-1702(02)00261-7","volume":"91","author":"TR Doel","year":"2003","unstructured":"Doel TR (2003) FMD vaccines. Virus Res 91(1):81\u201399","journal-title":"Virus Res"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.vetmic.2016.12.018","volume":"206","author":"F Diaz-San Segundo","year":"2017","unstructured":"Diaz-San Segundo F, Medina GN, Stenfeldt C et al (2017) Foot-and-mouth disease vaccines. Vet Microbiol 206:102\u2013112. https:\/\/doi.org\/10.1016\/j.vetmic.2016.12.018","journal-title":"Vet Microbiol"},{"issue":"1","key":"9_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1128\/JVI.74.1.272-280.2000","volume":"74","author":"GJ Belsham","year":"2000","unstructured":"Belsham GJ, McInerney GM, Ross-Smith N (2000) Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells. J Virol 74(1):272\u2013280","journal-title":"J Virol"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.coviro.2018.02.005","volume":"29","author":"T de Los Santos","year":"2018","unstructured":"de Los Santos T, Diaz-San Segundo F, Rodriguez LL (2018) The need for improved vaccines against foot-and-mouth disease. Curr Opin Virol 29:16\u201325. https:\/\/doi.org\/10.1016\/j.coviro.2018.02.005","journal-title":"Curr Opin Virol"},{"issue":"6","key":"9_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1586\/14760584.2016.1140042","volume":"15","author":"Y Cao","year":"2016","unstructured":"Cao Y, Lu Z, Liu Z (2016) Foot-and-mouth disease vaccines: progress and problems. Expert Rev Vaccines 15(6):783\u2013789. https:\/\/doi.org\/10.1586\/14760584.2016.1140042","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"9_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2217\/fvl.12.65","volume":"7","author":"MJ Grubman","year":"2012","unstructured":"Grubman MJ, Diaz-San Segundo F, Dias CC et al (2012) Use of replication-defective adenoviruses to develop vaccines and biotherapeutics against foot-and-mouth disease. Futur Virol 7(8):12","journal-title":"Futur Virol"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.21775\/9781910190517.14","volume-title":"Foot-and-mouth disease virus: current research and emerging trends","author":"F Diaz-San Segundo","year":"2017","unstructured":"Diaz-San Segundo F, Medina GN, Grubman MJ et al (2017) Control of foot-and-mouth disease by using replication-defective human adenoviruses to deliver vaccines and biotherapeutics. In: Sobrino F, Domingo E (eds) Foot-and-mouth disease virus: current research and emerging trends. Caister Academic Press, Poole, pp 333\u2013356"},{"issue":"4","key":"9_CR8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","volume":"10","author":"N Tatsis","year":"2004","unstructured":"Tatsis N, Ertl HC (2004) Adenoviruses as vaccine vectors. Mol Ther 10(4):616\u2013629. https:\/\/doi.org\/10.1016\/j.ymthe.2004.07.013","journal-title":"Mol Ther"},{"issue":"3","key":"9_CR9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a013003","volume":"25","author":"RC Hoeben","year":"2013","unstructured":"Hoeben RC, Uil TG (2013) Adenovirus DNA replication. Cold Spring Harb Perspect Biol 25(3):a013003. https:\/\/doi.org\/10.1101\/cshperspect.a013003","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.2741\/1607","volume":"10","author":"J Schaack","year":"2005","unstructured":"Schaack J (2005) Adenovirus vectors deleted for genes essential for viral DNA replication. Front Biosci 10:1146\u20131155. https:\/\/doi.org\/10.2741\/1607","journal-title":"Front Biosci"},{"issue":"1","key":"9_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","volume":"36","author":"FL Graham","year":"1977","unstructured":"Graham FL, Smiley J, Russell WC et al (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36(1):59\u201374. https:\/\/doi.org\/10.1099\/0022-1317-36-1-59","journal-title":"J Gen Virol"},{"issue":"13","key":"9_CR12","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1089\/hum.1998.9.13-1909","volume":"9","author":"FJ Fallaux","year":"1998","unstructured":"Fallaux FJ, Bout A, van der Velde I et al (1998) New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 9(13):1909\u20131917. https:\/\/doi.org\/10.1089\/hum.1998.9.13-1909","journal-title":"Hum Gene Ther"},{"issue":"2","key":"9_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1006\/viro.1999.9940","volume":"263","author":"GA Mayr","year":"1999","unstructured":"Mayr GA, Chinsangaram J, Grubman MJ (1999) Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology 263(2):496\u2013506. https:\/\/doi.org\/10.1006\/viro.1999.9940","journal-title":"Virology"},{"issue":"5","key":"9_CR14","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.2144\/01315st05","volume":"31","author":"MP Moraes","year":"2001","unstructured":"Moraes MP, Mayr GA, Grubman MJ (2001) pAd5-Blue: direct ligation system for engineering recombinant adenovirus constructs. BioTechniques 31(5):1050, 2, 4-6","journal-title":"BioTechniques"},{"issue":"11\u201312","key":"9_CR15","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/S0264-410X(01)00483-2","volume":"20","author":"MP Moraes","year":"2002","unstructured":"Moraes MP, Mayr GA, Mason PW et al (2002) Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 20(11\u201312):1631\u20131639","journal-title":"Vaccine"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.virol.2016.12.021","volume":"502","author":"I Fernandez-Sainz","year":"2017","unstructured":"Fernandez-Sainz I, Medina GN, Ramirez-Medina E et al (2017) Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine. Virology 502:123\u2013132. https:\/\/doi.org\/10.1016\/j.virol.2016.12.021","journal-title":"Virology"},{"issue":"2","key":"9_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.virol.2005.04.014","volume":"337","author":"JM Pacheco","year":"2005","unstructured":"Pacheco JM, Brum MC, Moraes MP et al (2005) Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 337(2):205\u2013209. https:\/\/doi.org\/10.1016\/j.virol.2005.04.014","journal-title":"Virology"},{"issue":"27","key":"9_CR18","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1016\/j.vaccine.2015.12.018","volume":"34","author":"C Schutta","year":"2016","unstructured":"Schutta C, Barrera J, Pisano M et al (2016) Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge. Vaccine 34(27):3214\u20133220. https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.018","journal-title":"Vaccine"},{"issue":"2","key":"9_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/tbed.12724","volume":"65","author":"J Barrera","year":"2018","unstructured":"Barrera J, Brake DA, Kamicker BJ et al (2018) Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle. Transbound Emerg Dis 65(2):447\u2013455. https:\/\/doi.org\/10.1111\/tbed.12724","journal-title":"Transbound Emerg Dis"},{"issue":"2","key":"9_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0264-410X(03)00560-7","volume":"22","author":"MP Moraes","year":"2003","unstructured":"Moraes MP, Chinsangaram J, Brum MC et al (2003) Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 22(2):268\u2013279","journal-title":"Vaccine"},{"issue":"2","key":"9_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.virol.2011.02.023","volume":"413","author":"F Diaz-San Segundo","year":"2011","unstructured":"Diaz-San Segundo F, Weiss M, Perez-Martin E et al (2011) Antiviral activity of bovine type III interferon against foot-and-mouth disease virus. Virology 413(2):283\u2013292. https:\/\/doi.org\/10.1016\/j.virol.2011.02.023","journal-title":"Virology"},{"issue":"8","key":"9_CR22","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1128\/JVI.06683-11","volume":"86","author":"E Perez-Martin","year":"2012","unstructured":"Perez-Martin E, Weiss M, Diaz-San Segundo F et al (2012) Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle. J Virol 86(8):4477\u20134487. https:\/\/doi.org\/10.1128\/JVI.06683-11","journal-title":"J Virol"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.virol.2016.09.027","volume":"499","author":"F Diaz-San Segundo","year":"2016","unstructured":"Diaz-San Segundo F, Montiel NA, Sturza DF et al (2016) Combination of Adt-O1Manisa and Ad5-boIFNlambda3 induces early protective immunity against foot-and-mouth disease in cattle. Virology 499:340\u2013349. https:\/\/doi.org\/10.1016\/j.virol.2016.09.027","journal-title":"Virology"},{"issue":"2","key":"9_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1128\/CVI.00426-15","volume":"23","author":"GN Medina","year":"2015","unstructured":"Medina GN, Montiel N, Diaz-San Segundo F et al (2015) Evaluation of a fiber-modified adenovirus vector vaccine against foot-and-mouth disease in cattle. Clin Vaccine Immunol 23(2):125\u2013136. https:\/\/doi.org\/10.1128\/CVI.00426-15","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"9_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023160","volume":"6","author":"DJ Haeussler","year":"2011","unstructured":"Haeussler DJ, Evangelista AM, Burgoyne JR et al (2011) Checkpoints in adenoviral production: cross-contamination and E1A. PLoS One 6(8):e23160. https:\/\/doi.org\/10.1371\/journal.pone.0023160","journal-title":"PLoS One"},{"issue":"3","key":"9_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.biologicals.2015.02.002","volume":"43","author":"R Kumar","year":"2015","unstructured":"Kumar R, Basagoudanavar SH, Sreenivasa BP (2015) Detection of replication competent adenovirus upon serial passaging of recombinant adenovirus expressing FMDV capsid proteins. Biologicals 43(3):209\u2013212. https:\/\/doi.org\/10.1016\/j.biologicals.2015.02.002","journal-title":"Biologicals"},{"key":"9_CR27","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot095604","volume":"8","author":"Q Su","year":"2020","unstructured":"Su Q, Sena-Esteves M, Gao G (2020) Purification of recombinant adeno-associated viruses (RAAVs) by cesium chloride gradient sedimentation. Cold Spring Harb Protoc 8:095604. https:\/\/doi.org\/10.1101\/pdb.prot095604","journal-title":"Cold Spring Harb Protoc"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.118.2.295","volume":"118","author":"WC Wilcox","year":"1963","unstructured":"Wilcox WC, Ginsberg HS (1963) Structure of type 5 adenovirus. I. Antigenic relationship of virus-structural proteins to virus-specific soluble antigens from infected cells. J Exp Med 118:295\u2013306. https:\/\/doi.org\/10.1084\/jem.118.2.295","journal-title":"J Exp Med"},{"issue":"1","key":"9_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jcb.20523","volume":"96","author":"P Ostapchuk","year":"2005","unstructured":"Ostapchuk P, Hearing P (2005) Control of adenovirus packaging. J Cell Biochem 96(1):25\u201335. https:\/\/doi.org\/10.1002\/jcb.20523","journal-title":"J Cell Biochem"},{"key":"9_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.105090","volume":"41","author":"J Ma","year":"2020","unstructured":"Ma J, Su C, Wang X, Shu Y et al (2020) A novel method to purify adenovirus based on increasing salt concentrations in buffer. Eur J Pharm Sci 41:105090. https:\/\/doi.org\/10.1016\/j.ejps.2019.105090","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"9_CR31","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/bit.26972","volume":"116","author":"J Turnbull","year":"2019","unstructured":"Turnbull J, Wright B, Green NK et al (2019) Adenovirus 5 recovery using nanofiber ion-exchange adsorbents. Biotechnol Bioeng 116(7):1698\u20131709. https:\/\/doi.org\/10.1002\/bit.26972","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"9_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","volume":"5","author":"MA Ramakrishnan","year":"2016","unstructured":"Ramakrishnan MA (2016) Determination of 50% endpoint titer using a simple formula. World J Virol 5(2):85\u201386. https:\/\/doi.org\/10.5501\/wjv.v5.i2.85","journal-title":"World J Virol"}],"container-title":["Methods in Molecular Biology","Vaccine Technologies for Veterinary Viral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2168-4_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T02:01:08Z","timestamp":1662170468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2168-4_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071621677","9781071621684"],"references-count":32,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2168-4_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"3 February 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}